These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A report from the Australian drug evaluation committee: oral contraceptives and thromboembolic disease. Med J Aust; 1970 Jun; 1(25):1267-9. PubMed ID: 5459269 [TBL] [Abstract][Full Text] [Related]
3. Breast cancer and oestrogen content of oral contraceptives. Bye P Lancet; 1984 Jan; 1(8370):223. PubMed ID: 6141361 [No Abstract] [Full Text] [Related]
12. Serious adverse effects of oral contraceptives and estrogens. Med Lett Drugs Ther; 1976 Feb; 18(5):21-2. PubMed ID: 1256357 [No Abstract] [Full Text] [Related]
13. Metabolic effects of oral contraceptives. Br Med J; 1970 Jul; 3(5715):121. PubMed ID: 5431079 [No Abstract] [Full Text] [Related]
14. [Letter: Thrombosis hazards due to estrogen dosage]. Lauritzen C Med Welt; 1974 May; 25(20):919-20. PubMed ID: 4845129 [No Abstract] [Full Text] [Related]
15. Comment on " Are oral contraceptives a significant contributor to the estrogenicity of drinking water?". Grzybowski W Environ Sci Technol; 2011 Sep; 45(17):7605; author reply 7606-7. PubMed ID: 21838254 [No Abstract] [Full Text] [Related]
16. Oestrogens and thromboembolism. Br Med J; 1970 Apr; 2(5703):189-90. PubMed ID: 5443398 [No Abstract] [Full Text] [Related]